Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26F9AZ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,365
Award facts
- Contract value 100% obligated
- $8,364.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of 36,000 units of Creon DR 100 strength capsules, with a ceiling value of $8,364.84 and an ultimate completion date of November 12, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly supplies pharmaceutical products and medical supplies to support military and veteran healthcare systems through the DLA Medical Supply Chain. The Indefinite Delivery Contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to provide a vast range of medications, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Creon, a pancreatic enzyme replacement therapy, exemplifies the company's role in fulfilling essential pharmaceutical commodities for federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9AZ4?
SPE2DR26F9AZ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26F9AZ4 worth?
The government has obligated $8,365 on SPE2DR26F9AZ4.
Is contract SPE2DR26F9AZ4 an order under another contract?
Yes. SPE2DR26F9AZ4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AZ4 competed?
The extent of competition for SPE2DR26F9AZ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award